Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2014
06/11/2014CN103857661A 1,2,4-triazolyl-substituted keto-enols
06/11/2014CN103857659A Fused benzoxazepinones as ion channel modulators
06/11/2014CN103849376A Method of preparing porphyrin nanogold composite material with core-shell structure
06/11/2014CN103848838A c-Met-VEGFR-2 double antagonist, preparation method and medical use thereof
06/11/2014CN103848837A Compound for reducing intraocular pressure and application thereof
06/11/2014CN103848836A Ticagrelor sesquihydrate and preparation method thereof
06/11/2014CN103848835A Dipeptidyl peptidase-IV inhibitor, application thereof, intermediate body thereof and preparation method of intermediate body thereof
06/11/2014CN103848834A Method for preparing ticagrelor and intermediate of ticagrelor
06/11/2014CN103848833A Pyrrolotriazines derivative, its preparation method and application of pyrrolotriazines derivative on medicine
06/11/2014CN103848829A Heteroaryl alkyne compounds and application thereof
06/11/2014CN103172641B Heterocyclic amino and alkoxy-replaced quinazoline derivative and application thereof
06/11/2014CN102491977B 1-substituted benzene oxymethylene-8-alkylthio-10-methylthio pyrimido [5,4-e]-1,2,triazole [1,5-c] pyrimidine possessing herbicidal activity and preparation method thereof
06/11/2014CN102405217B Azaazulene compounds
06/11/2014CN102382115B Synthetic method of indazole-phthalazine compound
06/11/2014CN102140100B Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof
06/11/2014CN102124006B Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
06/11/2014CN101784550B Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
06/10/2014US8748629 Photochromic material
06/10/2014US8748601 Selective serine/threonine kinase inhibitors
06/10/2014US8748439 Inhibitors of Bruton's tyrosine kinase
06/10/2014US8748438 Inhibitors of Bruton's tyrosine kinase
06/10/2014US8748435 Pyrazolo pyrimidine derivatives
06/10/2014US8748433 β3 adrenergic receptor agonists
06/10/2014US8748419 Treating obesity with muscarinic receptor M1 antagonists
06/10/2014CA2795080C Purine compounds
06/10/2014CA2663116C Inhibitors of bruton's tyrosine kinase
06/05/2014WO2014085489A1 Inhibitor of apoptosis protein (iap) antagonists
06/05/2014WO2014085284A1 Triazolo-pyrazine derivatives useful in the treatment of disorders of the central nervous system
06/05/2014WO2014084331A1 Pentafluorosulfanyl phthalocyanine derivative and intermediate thereof
06/05/2014WO2014083571A1 A process for the preparation of alcaftadine
06/05/2014WO2014083150A1 Preparation of 3-amino-piperidine compounds via nitro-tetrahydropyridine precursors
06/05/2014WO2014083139A1 Novel amorphous form of ticagrelor
06/05/2014WO2014082578A1 Heteroaryl alkyne compound and application thereof
06/05/2014WO2014082380A1 Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082230A1 Pyrrolotriazine derivative, preparation method thereof and application thereof in medicine
06/05/2014US20140155604 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
06/05/2014US20140155594 [1,2,4]Triazolo[1,5-a]Pyridine and [1,2,4]Triazolo[1,5-c]Pyrimidine Compounds and Their Use
06/05/2014US20140155593 Methods of synthesis and purification of heteroaryl compounds
06/05/2014US20140155590 Conjugates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
06/05/2014US20140155585 Haptens of risperidone and paliperidone
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155417 Compounds for modulating trpv3 function
06/05/2014US20140155416 Substituted pyrazolo[1,5-a] pyrimidines as calcium receptor modulating agents
06/05/2014US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
06/05/2014US20140155406 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk inhibitors
06/05/2014US20140155395 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
06/05/2014US20140155387 Anti-Inflammation Compounds
06/05/2014US20140155385 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk inhibitors
06/05/2014US20140155384 Compounds and methods of treating diabetes
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155376 Pyrrolopyrazine kinase inhibitors
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/05/2014US20140154240 Pyrazolo[1,5-a]pyrimidines for antiviral treatment
06/05/2014US20140154232 Use of Pl3K Inhibitors for the Treatment of Obesity, Steatosis and Ageing
06/05/2014US20140154179 Cxcr7 antagonists
06/04/2014EP2738174A2 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient
06/04/2014EP2738172A1 New bicyclic compounds as crac channel modulators
06/04/2014EP2738166A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
06/04/2014EP2736910A1 Pyrazoline derivatives and their use as selective androgen receptor modulators
06/04/2014EP2736909A1 Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
06/04/2014EP2736908A1 Bicyclic pyrimidone compounds
06/04/2014EP2736907A1 Indazoles
06/04/2014EP2736883A1 Nuclear transport modulators and uses thereof
06/04/2014CN103842364A Anti-viral compounds
06/04/2014CN103842363A Substituted imidazopyridines and the use thereof
06/04/2014CN103842362A Compositions and methods for treating Alzheimer's disease
06/04/2014CN103842340A Nuclear transport modulators and uses thereof
06/04/2014CN103842339A Carbazole derivatives for organic electroluminescence devices
06/04/2014CN103842338A Compounds with oxime ester and/or acyl groups
06/04/2014CN103833771A Benzo five-membered heterocyclic compound serving as protein kinase Mek inhibitor, preparation method and application thereof
06/04/2014CN103833763A Method of quickly preparing stable enteromorpha chlorophyll
06/04/2014CN103833762A Chlorine compound and preparation method thereof as well as medicine composition and application of chlorine compound and medicine composition
06/04/2014CN103833761A Compound crystal applicable to organic electronic devices
06/04/2014CN103833760A Piperazidines derivate
06/04/2014CN103833759A Pteridinone derivatives as BLK and FLT3 inhibitors and applications thereof
06/04/2014CN102936255B Separation method for Q[5]@Q[10]
06/04/2014CN102757434B Preparation method for industrial amplified production of anagrelide hydrochloride active pharmaceutical ingredient
06/04/2014CN102464667B Five-membered heterocycle pyrimidine compounds, preparation method and application thereof
06/04/2014CN102413831B Substituted imidazoquinoxalines
06/04/2014CN102311454B Compound lipid containing porphyrin ring functional groups, preparation method and application thereof
06/04/2014CN102124005B Cmet inhibitors
06/04/2014CN101687866B Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
06/03/2014US8742131 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof
06/03/2014US8742121 Process for the preparation of small molecule inhibitors of MDM2 and intermediates used therein
06/03/2014US8742107 Process for manufacturing bis(2-methoxyethyl)-2,3,6,7-tetracyano-1,4,5,8,9,10-hexazaanthracene
06/03/2014US8742101 Purine nucleoside analogues for treating flaviviridae including hepatitis C
06/03/2014US8741926 Macrocyclic inhibitors of hepatitis C virus
06/03/2014US8741912 Deazapurines useful as inhibitors of Janus kinases
06/03/2014US8741910 Soluble guanylate cyclase activators
06/03/2014US8741908 Inhibitors of bruton's tyrosine kinase
06/03/2014US8741907 Alkyl-substituted pyrazolopyrimidines
06/03/2014US8741906 [1,2,3]triazolo[4,5-D]pyrimidine derivatives
06/03/2014US8741897 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
06/03/2014US8741896 Pyrazolopyrimidine derivatives
06/03/2014US8741892 Compounds
06/03/2014US8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors
06/03/2014US8741884 Compounds for the treatment of hepatitis C
06/03/2014US8741491 Ionic liquid containing sulfonate ions
06/03/2014CA2788783C Heterocycles as potassium channel modulators
06/03/2014CA2621564C Pyridine derivatives and their use in the treatment of psychotic disorders
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 573